Financing ·
Shattuck Labs, Inc. entered into an underwriting agreement on June 9, 2026, to issue and sell 10,879,376 shares of…
STTKShattuck Labs, Inc.
Shattuck Labs, Inc. entered into an underwriting agreement on June 9, 2026, to issue and sell 10,879,376 shares of common stock at $4.00 per share and 7,870,624 pre-funded warrants to purchase common stock at $3.9999 per share. The underwriters, including J.P. Morgan Securities LLC and Leerink Partners LLC, were granted an option to purchase an additional 2,812,500 shares, which they exercised in full on June 10, 2026. The offering is expected to close on June 11, 2026. Shattuck Labs, Inc. is a biotechnology company focused on cannabis-based therapeutics.